KR20230109079A - Liquid crystal emulsion having an excellent effect on skin barrier improvement and skin moisturizing - Google Patents

Liquid crystal emulsion having an excellent effect on skin barrier improvement and skin moisturizing Download PDF

Info

Publication number
KR20230109079A
KR20230109079A KR1020220149460A KR20220149460A KR20230109079A KR 20230109079 A KR20230109079 A KR 20230109079A KR 1020220149460 A KR1020220149460 A KR 1020220149460A KR 20220149460 A KR20220149460 A KR 20220149460A KR 20230109079 A KR20230109079 A KR 20230109079A
Authority
KR
South Korea
Prior art keywords
weight
skin
liquid crystal
alcohol
moisturizing
Prior art date
Application number
KR1020220149460A
Other languages
Korean (ko)
Inventor
김을수
장수창
배순민
이소라
양소정
이경림
Original Assignee
(주)바이오코스텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)바이오코스텍 filed Critical (주)바이오코스텍
Priority to KR1020220149460A priority Critical patent/KR20230109079A/en
Publication of KR20230109079A publication Critical patent/KR20230109079A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0295Liquid crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 아라키딜알코올, 베헤닐알코올, 아라키딜글루코사이드, 솔비탄세스퀴올리에이트, 피토스테롤, 피토스핑고신, 세라마이드엔피, 옥틸도데칸올, 세테아릴알코올, 글리세릴스테아레이트, 팔미틱애씨드, 스테아릭애씨드, 미리스틱애씨드로 구성된 유화제 조성물을 에멀전 조성물에 적용함으로써 액정 형성이 우수한 액정 유화 조성물에 관한 것으로, 액정 유화 조성물을 피부에 적용 시에 피부 장벽 개선 및 피부 보습에 우수한 효과를 줄 수 있다. The present invention is arachidyl alcohol, behenyl alcohol, arachidyl glucoside, sorbitan sesquioleate, phytosterol, phytosphingosine, ceramide NP, octyldodecanol, cetearyl alcohol, glyceryl stearate, palmitic acid It relates to a liquid crystal emulsion composition with excellent liquid crystal formation by applying an emulsifier composition composed of stearic acid and myristic acid to an emulsion composition. there is.

Description

피부 장벽 개선 및 피부 보습에 우수한 효과를 갖는 액정 유화 조성물 {Liquid crystal emulsion having an excellent effect on skin barrier improvement and skin moisturizing}Liquid crystal emulsion having an excellent effect on skin barrier improvement and skin moisturizing {Liquid crystal emulsion having an excellent effect on skin barrier improvement and skin moisturizing}

본 발명은 피부 장벽 개선 및 피부 보습 효과를 갖는 액정 유화 조성물에 관한 것이다. 구체적으로는 아라키딜알코올(Arachidyl Alcohol), 베헤닐알코올(Behenyl Alcohol), 아라키딜글루코사이드(Arachidyl Glucoside), 솔비탄세스퀴올리에이트(Sorbitan Sesquioleate), 피토스테롤(Phytosterols), 피토스핑고신(Phytosphingosine), 세라마이드엔피(Ceramide NP), 옥틸도데칸올(Octyldodecanol), 세테아릴알코올(Cetearyl Alcohol), 글리세릴스테아레이트 (Glyceryl Stearate), 팔미틱애씨드(Palmitic Acid), 스테아릭애씨드(Stearic Acid), 미리스틱애씨드(Myristic Acid) 로 구성된 유화제 조성물을 에멀전 조성물에 적용함으로써, 피부 장벽 개선과 피부 보습에 우수한 효과가 있는 액정 유화 조성물에 관한 것이다.The present invention relates to a liquid crystal emulsion composition having skin barrier improvement and skin moisturizing effect. Specifically, Arachidyl Alcohol, Behenyl Alcohol, Arachidyl Glucoside, Sorbitan Sesquioleate, Phytosterols, Phytosphingosine , Ceramide NP, Octyldodecanol, Cetearyl Alcohol, Glyceryl Stearate, Palmitic Acid, Stearic Acid, It relates to a liquid crystal emulsion composition having an excellent effect on skin barrier improvement and skin moisturizing by applying an emulsifier composition composed of myristic acid to an emulsion composition.

피부는 인체의 가장 큰 기관으로 알려져 있다. 피부는 몸을 덮음으로써, 모든 기관 중 가장 큰 표면을 차지한다. 피부는 장벽조직으로 작용하여 침입자들이 들어올 수 없는 경계를 형성하고 있기 때문에 1차 방어선이다. 피부로 신체의 바깥 면을 감싸는 것으로 중요한 방어 기능을 한다. 표피는 과도한 수분손실이나 물리적 손상 그리고 해로운 화학물질로부터 깊은 쪽에 위치하는 조직을 보호한다.The skin is known as the largest organ of the human body. As the skin covers the body, it occupies the largest surface area of all organs. The skin is the first line of defense because it acts as a barrier tissue and forms a boundary that intruders cannot enter. The skin, which covers the outer surface of the body, serves an important defensive function. The epidermis protects the deeper tissue from excessive water loss, physical damage, and harmful chemicals.

각질층은 피부 표면에서 각질세포가 납작해지고, 핵은 세포 가장자리로 밀려나면서 각질층이 생성된다. 피부의 맨 바깥의 얇은 껍질의 층을 말한다. 세포는 편평, 투명하고 각질화되어 있다. 내부조직의 수분의 증발을 막고 보호하는 기능을 한다.In the stratum corneum, keratinocytes are flattened on the surface of the skin, and the nucleus is pushed to the edge of the cell, forming the stratum corneum. It is the thin outermost layer of the skin. Cells are flat, transparent and keratinized. It functions to prevent and protect the evaporation of moisture in the internal tissues.

피부가 건조하게 되면 비늘을 보이고 표면이 거친 피부 상태가 되어 건조함으로 인해 불편감을 느낄 수 있다. 피부 건조를 개선하기 위해서는 각질층의 수분 손실을 최소화하면서 각질층에 수분을 공급하고 유지시키는 것이다.When the skin becomes dry, scales appear and the surface becomes rough, which can cause discomfort due to dryness. In order to improve skin dryness, it is to supply and maintain moisture in the stratum corneum while minimizing water loss in the stratum corneum.

액정 크림은 에멀젼 속에서 분산입자들을 둘러싼 라멜라 구조로 피부 보호막을 형성하고 수분 손실을 방어해 줄 수 있다. 피부지질층과 유사하여 피부 베리어 기능을 향상시키는 도움을 준다. 각질층의 라멜라 구조는 인지질로 구성된 일종의 다중층상 구조의 형태이며, 이는 오일막과 수상막이 차례로 쌓아놓은 상태이다. 액정크림 속의 라멜라 구조는 실제 피부지질층과 매우 유사하며, 이러한 구조로 인하여 피부의 수분이 보호될 수 있다. 일반적인 크림을 피부에 도포하였을 때 수분이 빠르게 증발하여 보습효과가 감소되나, 라멜라 구조의 액정 크림은 수분의 증발을 막아주어 수분 보유능이 향상된다. Liquid crystal cream can form a protective film on the skin and protect against moisture loss with a lamellar structure surrounding the dispersed particles in the emulsion. Similar to the skin lipid layer, it helps to improve the skin barrier function. The lamellar structure of the stratum corneum is a kind of multi-layered structure composed of phospholipids, in which an oil film and a dendritic film are sequentially stacked. The lamellar structure in the liquid crystal cream is very similar to the actual skin lipid layer, and due to this structure, the moisture of the skin can be protected. When a general cream is applied to the skin, moisture evaporates quickly and the moisturizing effect is reduced.

공개특허 10-2019-0070644 (액정형성능력이 우수한 유화제 조성물 및 이를 함유하는 화장료 조성물)Publication No. 10-2019-0070644 (Emulsifier composition with excellent liquid crystal forming ability and cosmetic composition containing the same)

액정 유화 조성물을 개발하는 것을 목적으로 한다. It aims to develop a liquid crystal emulsion composition.

보습 및 피부장벽 개선에 우수한 액정 유화 에멀전 조성물을 제공하는 것을 목적으로 한다. It is an object of the present invention to provide a liquid crystal emulsified emulsion composition excellent in moisturizing and skin barrier improvement.

액정 생성에 최적의 조성비로 구성된 액정 유화 조성물을 개발하는 것을 목적으로 한다.The purpose is to develop a liquid crystal emulsion composition composed of an optimal composition ratio for liquid crystal generation.

따라서 아라키딜알코올(Arachidyl Alcohol), 베헤닐알코올(Behenyl Alcohol), 아라키딜글루코사이드(Arachidyl Glucoside), 솔비탄세스퀴올리에이트(Sorbitan Sesquioleate), 피토스테롤(Phytosterols), 피토스핑고신(Phytosphingosine), 세라마이드엔피(Ceramide NP), 옥틸도데칸올(Octyldodecanol), 세테아릴알코올(Cetearyl Alcohol), 글리세릴스테아레이트 (Glyceryl Stearate), 팔미틱애씨드(Palmitic Acid), 스테아릭애씨드(Stearic Acid), 미리스틱애씨드(Myristic Acid)가 최적의 조성비로 구성된 유화제 조성물을 에멀전 조성물에 적용하여 피부 보습에 우수하고, 피부 장벽 개선에 도움을 주는 액정 유화 조성물을 개발하는 것을 목적으로 한다. Therefore, Arachidyl Alcohol, Behenyl Alcohol, Arachidyl Glucoside, Sorbitan Sesquioleate, Phytosterols, Phytosphingosine, Ceramide Ceramide NP, Octyldodecanol, Cetearyl Alcohol, Glyceryl Stearate, Palmitic Acid, Stearic Acid, Myristic The purpose is to develop a liquid crystal emulsion composition that is excellent in moisturizing the skin and helps improve the skin barrier by applying an emulsifier composition composed of Myristic Acid in an optimal composition ratio to the emulsion composition.

상기 목적을 달성하기 위해 본 발명은 피부 장벽 개선 및 피부 보습에 우수한 효과를 갖는 액정 유화 조성물을 제공한다. In order to achieve the above object, the present invention provides a liquid crystal emulsion composition having excellent effects on skin barrier improvement and skin moisturizing.

본 발명에서 액정구조를 형성시키는 아라키딜알코올(Arachidyl Alcohol), 베헤닐알코올(Behenyl Alcohol), 아라키딜글루코사이드(Arachidyl Glucoside), 솔비탄세스퀴올리에이트(Sorbitan Sesquioleate), 피토스테롤(Phytosterols), 피토스핑고신(Phytosphingosine), 세라마이드엔피(Ceramide NP), 옥틸도데칸올(Octyldodecanol), 세테아릴알코올(Cetearyl Alcohol), 글리세릴스테아레이트 (Glyceryl Stearate), 팔미틱애씨드(Palmitic Acid), 스테아릭애씨드(Stearic Acid), 미리스틱애씨드(Myristic Acid)로 이루어진 유화제 조성물이 제공된다. In the present invention, arachidyl alcohol, behenyl alcohol, arachidyl glucoside, sorbitan sesquioleate, phytosterols, and phytos that form the liquid crystal structure Phytosphingosine, Ceramide NP, Octyldodecanol, Cetearyl Alcohol, Glyceryl Stearate, Palmitic Acid, Stearic Acid (Stearic Acid), an emulsifier composition consisting of myristic acid (Myristic Acid) is provided.

아라키딜알코올은 아라키딕 산(Arachidic Acid) 또는 아라키돈산(arachidonic acid)의 수소화를 통해 얻어지는 탄소수 20의 지방알코올이다. 왁스로 연화제로써 사용되며, 유화 안정에 도움을 준다. Arachidyl alcohol is a fatty alcohol having 20 carbon atoms obtained through hydrogenation of arachidic acid or arachidonic acid. It is used as a softening agent as a wax and helps to stabilize the emulsion.

베헤닐알코올은 채종 환원알코올에서 분취 정제한 탄소수 22의 포화고급알코올이다. 탄소수가 크고, 안전성이 높으며 유화안정성이 뛰어나다. 또 에멀젼에 첨가하면 높은 점성이 생기기 때문에 에멀젼의 증점제로서 사용된다.Behenyl alcohol is a saturated higher alcohol with 22 carbon atoms obtained by fractionation and purification from reduced alcohol. It has high carbon number, high safety, and excellent emulsion stability. In addition, when added to an emulsion, it is used as a thickener of the emulsion because high viscosity is generated.

아라키딜글루코사이드는 아라키딜알코올과 글루코스의 축합반응으로 얻은 물질이다. 피부를 부드럽고 유연하게 연화시키는 데 도움을 주고, 화장품에서 서로 섞이지 않는 다른 성분들의 유화 안정에 도움을 준다.Arachidyl glucoside is a substance obtained from the condensation reaction of arachidyl alcohol and glucose. It helps to soften the skin softly and supplely, and helps to stabilize the emulsification of other ingredients that do not mix with each other in cosmetics.

세테아릴알코올은 세틸 및 스테아릴알코올로 구성된 지방알코올의 혼합물이다. 피부 속 수분을 저장하여 보습제로 사용되고, 피부결을 매끄럽고 곱게 가꿔 피부를 우연해지게 하는데 도움을 준다. 유화 안정제로도 사용된다. Cetearyl alcohol is a mixture of fatty alcohols composed of cetyl and stearyl alcohol. It is used as a moisturizer by storing moisture in the skin, and helps to make the skin texture smooth and fine. It is also used as an emulsion stabilizer.

글리세릴스테아레이트는 글리세린과 스테아릭애씨드의 혼합물로 피부 표면에 보호장벽을 형성함으로써 피부의 수분 손실을 막아주며, 유화 안정에 도움을 준다.Glyceryl stearate is a mixture of glycerin and stearic acid that forms a protective barrier on the skin surface to prevent skin moisture loss and helps to stabilize the emulsion.

팔미틱애씨드는 동식물의 유지 성분으로 자연계에 널리 분포되어 있는 탄소수 16의 포화지방산이다. 피부에 보습막을 형성하여 수분 유지를 도와주며, 유화제와 세정제의 역할에도 사용된다. Palmitic acid is a saturated fatty acid with 16 carbon atoms widely distributed in nature as an oil and fat component of animals and plants. It forms a moisturizing film on the skin to help retain moisture, and is also used as an emulsifier and cleanser.

스테아릭애씨드는 탄소수 18의 포화 고급지방산이다. 글리세롤과의 에스터로 널리 동식물계의 유지(油脂)나 인지질(燐脂質)에 함유되어 있고 천연으로는 가장 다량으로 존재하는 지방산이다. 유화 안정에 도움을 주며, 세정제로서도 사용한다. Stearic acid is a saturated higher fatty acid with 18 carbon atoms. As an ester with glycerol, it is widely contained in fats and oils and phospholipids of animal and vegetable systems, and is the most abundant fatty acid in nature. It helps to stabilize the emulsion and is also used as a detergent.

미리스틱애씨드는 글리세리드의 형으로 널리 동식물유 지방 중에 분포하는 탄소수 14개의 일염기성 노르말 사슬 포화 지방산이다. 소포제, 세정제 등으로 사용한다. Myristic acid is a monobasic normal chain saturated fatty acid with 14 carbon atoms widely distributed in animal and vegetable oil fats in the form of glycerides. It is used as an antifoaming agent, cleaning agent, etc.

솔비탄세스퀴올리에이트는 소르비탄 또는 소르바이드의 올리인산디에스텔로 되어 있어 유화에 도움을 준다.Sorbitan sesquioleate is composed of sorbitan or sorbide oleophosphoric acid diester, which helps in emulsification.

본 발명에 바람직한 양태에 따르면, 유화제 조성물 전체 중량에 대하여 아라키딜알코올(5 내지 30 중량%), 베헤닐알코올(3 내지 20 중량%), 아라키딜글루코사이드(1 내지 10 중량%), 솔비탄세스퀴올리에이트(1 내지 10 중량%), 피토스테롤(1 내지 5 중량%), 피토스핑고신(0.1 내지 1 중량%), 세라마이드엔피(0.1 내지 1 중량%), 옥틸도데칸올(1 내지 10 중량%), 세테아릴알코올(5 내지 50 중량%), 글리세릴스테아레이트(5 내지 50 중량%) , 팔미틱애씨드(1 내지 30 중량%), 스테아릭애씨드(1 내지 20 중량%), 미리스틱애씨드(0.1 내지 1 중량%) 로 구성된 유화제 조성물을 포함할 수 있다. 액정 형성이 가장 우수하게 나타나는 유화제 조성물의 비율은 아라키딜알코올(27 중량%), 베헤닐알코올(15 중량%), 아라키딜글루코사이드(7 중량%), 솔비탄세스퀴올리에이트(1 중량%), 피토스테롤(1 중량%), 피토스핑고신(0.1 중량%), 세라마이드엔피(0.1 중량%), 옥틸도데칸올(9.6 중량%), 세테아릴알코올(9.8 중량%), 글리세릴스테아레이트(19.6 중량%) , 팔미틱애씨드(5.4 중량%), 스테아릭애씨드(4.3 중량%), 미리스틱애씨드(0.1 중량%)의 비율이다.According to a preferred embodiment of the present invention, arachidyl alcohol (5 to 30% by weight), behenyl alcohol (3 to 20% by weight), arachidyl glucoside (1 to 10% by weight), sorbitances based on the total weight of the emulsifier composition Quioleate (1 to 10% by weight), phytosterol (1 to 5% by weight), phytosphingosine (0.1 to 1% by weight), ceramide NP (0.1 to 1% by weight), octyldodecanol (1 to 10 % by weight), cetearyl alcohol (5 to 50% by weight), glyceryl stearate (5 to 50% by weight), palmitic acid (1 to 30% by weight), stearic acid (1 to 20% by weight), It may include an emulsifier composition composed of myristic acid (0.1 to 1% by weight). The ratio of the emulsifier composition showing the best liquid crystal formation is arachidyl alcohol (27% by weight), behenyl alcohol (15% by weight), arachidyl glucoside (7% by weight), sorbitan sesquioleate (1% by weight) , Phytosterol (1% by weight), Phytosphingosine (0.1% by weight), Ceramide NP (0.1% by weight), Octyldodecanol (9.6% by weight), Cetearyl Alcohol (9.8% by weight), Glyceryl Stearate (19.6% by weight), palmitic acid (5.4% by weight), stearic acid (4.3% by weight), and myristic acid (0.1% by weight).

상기 유화제 조성물은 액정 유화 조성물 전체 중량에 대하여 10 중량%로 사용된다. The emulsifier composition is used in an amount of 10% by weight based on the total weight of the liquid crystal emulsion composition.

상기 액정 유화 조성물은 부틸렌글라이콜(Butylene Glycol), 카프릴릭/카프릭트라이글리세라이드(Caprylic/Capric Triglyceride), 아이소노닐아이소노나노에이트(Isononyl Isononanoate), 하이드록시에칠아크릴레이트/소듐아크릴로일디메칠타우레이트코폴리머(Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer), 1,2-헥산다이올 (1,2-Hexanediol)을 추가적으로 포함한다.The liquid crystal emulsion composition is butylene glycol, caprylic / capric triglyceride, isononyl isononanoate, hydroxyethyl acrylate / sodium Acryloyldimethyl Taurate Copolymer (Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer) and 1,2-hexanediol (1,2-Hexanediol) are additionally included.

상기 액정 유화 조성물은 피부장벽개선 및 피부 보습 개선에 효과가 있다.The liquid crystal emulsion composition is effective in improving skin barrier and skin moisturizing.

본 발명의 유화제 조성물은 아라키딜알코올, 베헤닐알코올, 아라키딜글루코사이드, 솔비탄세스퀴올리에이트, 피토스테롤, 피토스핑고신, 세라마이드엔피, 옥틸도데칸올, 세테아릴알코올, 글리세릴스테아레이트, 팔미틱애씨드, 스테아릭애씨드, 미리스틱애씨드로 구성되어 에멀전 조성물에 적용하여 우수한 액정을 만들 수 있다. 액정 유화 조성물을 적용함으로써 피부장벽개선 및 피부 보습 개선을 할 수 있는 효과가 있다. The emulsifier composition of the present invention contains arachidyl alcohol, behenyl alcohol, arachidyl glucoside, sorbitan sesquioleate, phytosterol, phytosphingosine, ceramide NP, octyldodecanol, cetearyl alcohol, glyceryl stearate, Composed of palmitic acid, stearic acid, and myristic acid, it can be applied to an emulsion composition to create excellent liquid crystals. By applying the liquid crystal emulsion composition, there is an effect of improving the skin barrier and improving skin moisturizing.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 제조예, 실시예와 시험예들을 통하여 본 발명을 상세하게 설명하지만, 본 발명이 이 예들에 의하여 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail through examples. Although the present invention is described in detail through preparation examples, examples and test examples, the present invention is not limited by these examples.

[실시예][Example]

실시예 1 내지 6: 유화제 조성물Examples 1 to 6: Emulsifier composition

하기 표 1에 나타낸 실시예 1 내지 6의 조성에 따라 유화제 조성물을 제조하였다. Emulsifier compositions were prepared according to the compositions of Examples 1 to 6 shown in Table 1 below.

실시예 Example 1 One 2 2 3 3 4 4 5 5 6 6 1 One 아라키딜알코올 Arachidyl Alcohol 27 27 27.0 27.0 27.0 27.0 27.0 27.0 27.0 27.0 27.0 27.0 2 2 베헤닐알코올 behenyl alcohol 15 15 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 3 3 아라키딜글루코사이드 arachidyl glucoside 7 7 7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0 4 4 솔비탄세스퀴올리에이트Sorbitan Sesquioleate 1 One 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 5 5 피토스테롤 phytosterols 1 One 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 6 6 피토스핑고신 phytosphingosine 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 7 7 세라마이드엔피 Ceramide NP 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 8 8 옥틸도데칸올 Octyldodecanol 9.8 9.8 9.8 9.8 9.5 9.5 9.6 9.6 9.6 9.6 9.6 9.6 9 9 세테아릴알코올 Cetearyl Alcohol 39.0 39.0 - - - - 19.6 19.6 9.8 9.8 9.8 9.8 1010 글리세릴스테아레이트 Glyceryl Stearate - - 39.0 39.0 - - 9.8 9.8 19.6 19.6 9.8 9.8 1111 팔미틱애씨드 Palmitic Acid - - - - 21.6 21.6 5.4 5.4 5.4 5.4 10.8 10.8 1212 스테아릭애씨드 Stearic Acid - - - - 17.3 17.3 4.3 4.3 4.3 4.3 8.6 8.6 1313 미리스틱애씨드 myristic acid - - - - 0.4 0.4 0.1 0.1 0.1 0.1 0.2 0.2

실시예 7 내지 12: 액정 유화 조성물Examples 7 to 12: liquid crystal emulsion composition

상기 실시예 1 내지 6 의 유화제 조성료를 사용하여 하기 표2의 액정 유화 조성물을 제조하였다.Liquid crystal emulsion compositions in Table 2 below were prepared using the emulsifier compositions of Examples 1 to 6.

먼저 표2에 나타낸 성분들 중에 성분 1 내지 3을 75℃로 가온하고 성분4를 분산시킨 다음, 성분 5 내지 12를 75℃ 로 가온하여 HOMO MIXER를 사용하여 3500rpm으로 5분간 유화하고 32℃로 냉각하여 액정 유화 조성물을 완성하였다. 각 성분의 함량 단위는 그램(g)이다. First, among the components shown in Table 2, components 1 to 3 were warmed to 75 ° C, component 4 was dispersed, and then components 5 to 12 were heated to 75 ° C, emulsified for 5 minutes at 3500 rpm using a HOMO MIXER, and cooled to 32 ° C. The liquid crystal emulsion composition was completed. The unit of content of each component is grams (g).

실시예Example 77 88 99 1010 1111 1212 1One 정제수Purified water 잔량balance 잔량balance 잔량balance 잔량balance 잔량balance 잔량balance 22 부틸렌글라이콜Butylene Glycol 1010 1010 1010 1010 1010 1010 33 1,2-헥산다이올1,2-Hexanediol 22 22 22 22 22 22 44 하이드록시에칠아크릴레이트/소듐아크릴로일디메칠타우레이트코폴리머Hydroxyethyl Acrylate/Sodium Acryloyl Dimethyl Taurate Copolymer 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 55 실시예 1Example 1 1010 -- -- -- -- -- 66 실시예 2Example 2 -- 1010 -- -- -- -- 77 실시예 3Example 3 -- -- 1010 -- -- -- 88 실시예 4Example 4 -- -- -- 1010 -- -- 99 실시예 5Example 5 -- -- -- -- 1010 -- 1010 실시예 6Example 6 -- -- -- -- -- 1010 1111 카프릭트라이글리세라이드capric triglyceride 7.57.5 7.57.5 7.57.5 7.57.5 7.57.5 7.57.5 1212 아이소노닐아이소노나노에이트Isononylisononanoate 7.57.5 7.57.5 7.57.5 7.57.5 7.57.5 7.57.5

실험예 1: 액정 형성 관찰 Experimental Example 1: Observation of liquid crystal formation

실시예 7Example 7

실시예 8Example 8

실시예 9Example 9

실시예 10Example 10

실시예 11Example 11

실시예 12Example 12

실험예 2: 온도 안정도 액정 형성 관찰Experimental Example 2: Observation of temperature stability liquid crystal formation

상기의 실시예 7 내지 12로 제조되어진 액정 유화 조성물을 20℃, 40℃, 50℃, cycle(25℃→45℃→25℃→-5℃)에서 1개월간 안정도를 검토하여 액정 상태를 관찰하여 표3에 나타냈다. The liquid crystal emulsion composition prepared in Examples 7 to 12 was examined for stability for 1 month at 20 ° C, 40 ° C, 50 ° C, cycle (25 ° C → 45 ° C → 25 ° C → -5 ° C) to observe the liquid crystal state shown in Table 3.

실시예7Example 7 실시예8Example 8 실시예9Example 9 실시예10Example 10 실시예11Example 11 실시예12Example 12 20℃20℃ 22 44 55 22 1One 33 40℃40℃ 22 44 66 22 1One 55 50℃50℃ 33 55 66 33 22 55 CycleCycle 33 44 66 22 1One 55

* 평가기준* Evaluation standard

1: 액정상의 빈도가 우수함, 입자의 크기가 균일함.1: The frequency of the liquid crystal phase is excellent, and the particle size is uniform.

2: 액정상의 빈도가 양호함, 입자의 크기가 균일함2: The frequency of the liquid crystal phase is good, and the size of the particles is uniform.

3: 액정상의 빈도가 양호함, 입자의 크기가 불균일함.3: The frequency of the liquid crystal phase is good, and the size of the particles is non-uniform.

4: 액정상의 빈도가 미흡함. 입자의 크기가 균일함.4: The frequency of the liquid crystal phase is insufficient. The particle size is uniform.

5: 액정상의 빈도가 미흡함. 입자의 크기가 불균일함.5: The frequency of the liquid crystal phase is insufficient. Particle size is non-uniform.

6: 액정상이 보이지 않음6: liquid crystal phase not visible

실험예 3: 경표피수분손실량 (TEWL) 평가Experimental Example 3: Evaluation of transepidermal water loss (TEWL)

상기의 실시예 7 내지 12로 제조되어진 액정 유화 조성물에서 액정형성이 가장 우수한 실시예 11 액정 유화 조성물를 20-50세의 성인 12명의 피험자를 대상으로 2주 동안 시험제품과 대조제품을 1일 2회 아침 저녁 샤워 후 안면부위에 사용하게 한 후에 사용 후 직후, 4일, 2주차에 경표피수분손실량을 측정하였다. Dermalab USB TEWL probe를 사용하여 이마와 오른쪽 볼 중앙을 측정하였다. Dermalab USB 전용 분석 프로그램 .Application softwareversion 1.09를 이용하여 경표피수분손실량을 분석하였다. 인체적용시험대상자의 측정 부위를 수직으로 probe를 접촉하여 값이 읽히는 동안 수평을 유지시키면서 3회 반복 측정하였으며, 평균값을 계산하여 제품사용 전후의 경표피 수분 손실량을 비교평가하여 하기 표4에 나타냈다. In the liquid crystal emulsion composition prepared in Examples 7 to 12, the liquid crystal formation of Example 11 was the most excellent, and the liquid crystal emulsion composition of Example 11 was applied to 12 adult subjects aged 20-50 for 2 weeks with a test product and a control product twice a day. After showering in the morning and evening, the skin was applied to the face, and the amount of transepidermal water loss was measured immediately after use, 4 days, and 2 weeks after use. The forehead and the center of the right cheek were measured using the Dermalab USB TEWL probe. Transepidermal water loss was analyzed using Dermalab USB dedicated analysis program .Application softwareversion 1.09. The measurement site of the human body application test subject was vertically contacted with the probe and measured three times while keeping it horizontal while the value was read. The average value was calculated and the transepidermal water loss before and after product use was comparatively evaluated and shown in Table 4 below

Dermalab USB TEWL Probe를 적용하여 경표피수분손실량을 분석하였다. 분석된 TEWL값은 피부수분의 손실량을 나타내어 낮을수록 피부상태가 좋음을 의미한다. 실험결과, 인체적용시험 대상자 두 시험부위 모두 경표피수분손실량이 감소하였으며, 부위의 평균값은 초기 피부상태(방문1) 측정 시 16.51에서 사용 11일차에 12.4로 감소하여 (4.11 감소) 사용일차가 증가함에 따라 안면 경표피수분손실량이 감소함을 확인하였다.Dermalab USB TEWL Probe was applied to analyze transepidermal water loss. The analyzed TEWL value represents the loss of skin moisture, and the lower the value, the better the skin condition. As a result of the experiment, the amount of transepidermal water loss decreased in both test sites of the subjects of the human application test. As a result, it was confirmed that the amount of facial transepidermal water loss decreased.

제품사용일차 별 TEWL값을 시험제품사용에 의한 경표피 수분손실 개선률로 나타내기 위하여 아래 수식에 따라 계산하였으며,In order to express the TEWL value for each day of product use as the improvement rate of transepidermal water loss by using the test product, it was calculated according to the formula below,

개선율(%) = 100-[초기피부TEWL값/사용일차TEWL값x 100]Improvement rate (%) = 100 - [initial skin TEWL value / first day TEWL value x 100]

경표피수분손실 개선률은 초기피부 값과 각 제품사용일차 값을 비교하여 평가 하여 하기 표5에 나타냈다. The rate of improvement in transepidermal water loss was evaluated by comparing the initial skin value and the first day value of each product use, and is shown in Table 5 below.

시험부위의 시험제품사용에 의한 피부보습 개선율을 확인하기 위하여 초기피부 값과 각 사용일차 값을 비교하였다. 11일차에 오른쪽 볼 중앙을 측정하였을 때 25.09%로 가장 높은 개선율을 보였으며 부위의 평균값은 4일차 17.04%, 11일차에 24.91%로 사용할수록 피부표면의 수분 손실 개선률이 증가하며 경표피 수분유지효능이 있음을 확인하였다. In order to confirm the skin moisturizing improvement rate by using the test product in the test area, the initial skin value and the value of each day of use were compared. When the center of the right cheek was measured on the 11th day, the highest improvement rate was 25.09%, and the average value of the area was 17.04% on the 4th day and 24.91% on the 11th day. It was confirmed that there is efficacy.

방문visit 이마중앙center of forehead 오른쪽 볼 중앙right ball center 평균average 방문1visit 1 16.61±4.2916.61±4.29 16.42±5.9116.42±5.91 16.5116.51 방문1 (사용직후)Visit 1 (immediately after use) 16.17±5.3316.17±5.33 16.39±4.0916.39±4.09 16.2616.26 방문2 (사용 4일차)Visit 2 (4th day of use) 13.7±5.7913.7±5.79 13.7±5.9213.7±5.92 13.713.7 방문3 (사용 11일차)Visit 3 (Day 11 of use) 12.5±2.7612.5±2.76 12.3±4.9912.3±4.99 12.412.4

이마중앙center of forehead 오른쪽 볼 중앙right ball center 평균average 방문1(초기피부)-방문1(사용직후)Visit 1 (early skin) - Visit 1 (immediately after use) 2.642.64 0.360.36 1.51.5 방문1(초기피부)-방문2(사용4일차)Visit 1 (early skin) - Visit 2 (4th day of use) 17.5117.51 16.5616.56 17.0417.04 방문1(초기피부)-방문3(사용11일차)Visit 1 (early skin) - Visit 3 (Day 11 of use) 24.7424.74 25.0925.09 24.9124.91

실험예 4: 피부보습 수분함량 평가Experimental Example 4: Evaluation of skin moisturizing moisture content

상기의 실시예 7 내지 12로 제조되어진 액정 유화 조성물에서 액정형성이 가장 우수한 실시예 11 액정 유화 조성물을 20-50세의 성인 12명의 피험자를 대상으로 2주 동안 시험제품과 대조제품을 1일 2회 아침 저녁 샤워 후 안면부위에 사용하게 한 후에 사용 후 직후, 4일, 2주차에 피부보습 수분함량을 측정하였다. 피부 수분함량은 MPA 5의 Corneometer CM 825를 이용하여 비침습적 방법으로 측정하였다. Coneometer는 각질층 30~40um 깊이 이내의 수분함량을 측정하는 기기로 임의 단위 Arbitra unit(AU)로 표시한다. 측정 시 마다 측정 후 부드러운 티슈로 탐침표면을 닦았으며, 시험부위(이마, 오른쪽 볼 중앙) 당 3회씩 반복 측정하여 평균을 사용하여 하기 표6에 나타냈다. In the liquid crystal emulsion composition prepared in Examples 7 to 12, the liquid crystal formation of Example 11 was the most excellent, and the liquid crystal emulsion composition of Example 11 was administered to 12 adult subjects aged 20-50 for 2 weeks with a test product and a control product 2 times a day. After using it on the face after taking a shower in the morning and evening, the skin moisturizing moisture content was measured immediately after use, 4 days, and 2 weeks after use. Skin moisture content was measured non-invasively using a Corneometer CM 825 of MPA 5. Coneometer is a device that measures the water content within 30~40um depth of the stratum corneum, and is expressed in Arbitra unit (AU). After each measurement, the probe surface was wiped with a soft tissue after each measurement, and the measurement was repeated three times per test site (forehead, right cheek center), and the average was shown in Table 6 below.

Corneometer CM 825를 이용하여 수분함량을 분석하였다. 분석된 AU값은 피부표면의 수분함량을 나타내어 높을수록 피부상태가 좋음을 의미한다. 이마중앙 부위 측정결과 초기피부에 비해 제품 사용 11일차에서 수분함량이 다소 감소하였으나, 인체적용시험 대상자 두 시험부위의 평균값을 사용 일차에 따라 비교한 결과, 초기피부보다 사용11일차에 수분함량이 증가하였다. Moisture content was analyzed using Corneometer CM 825. The analyzed AU value represents the moisture content of the skin surface, and the higher the AU value, the better the skin condition. As a result of measuring the center of the forehead, the moisture content decreased slightly on the 11th day of product use compared to the initial skin, but as a result of comparing the average values of the two test sites of the subjects for the human application test according to the day of use, the moisture content increased on the 11th day of use compared to the initial skin did

방문visit 이마중앙center of forehead 오른쪽 볼 중앙right ball center 평균average 방문1visit 1 70.35±8.670.35±8.6 28.78±17.9728.78±17.97 49.5649.56 방문1 (사용직후)Visit 1 (immediately after use) 78.4±6.478.4±6.4 19.4±15.3119.4±15.31 48.948.9 방문2 (사용 4일차)Visit 2 (4th day of use) 65.9±5.9265.9±5.92 34.5±12.5734.5±12.57 50.250.2 방문3 (사용 11일차)Visit 3 (Day 11 of use) 65.3±6.4565.3±6.45 38.4±15.4138.4±15.41 51.8551.85

실험예 5: 피부보습 만족도 평가Experimental Example 5: Skin moisturizing satisfaction evaluation

상기의 실시예 7 내지 12로 제조되어진 액정 유화 조성물에서 액정형성이 가장 우수한 실시예 11 액정 유화 조성물를 20-50세의 성인 12명의 피험자를 대상으로 2주 동안 시험제품과 대조제품을 1일 2회 아침 저녁 샤워 후 안명부위에 사용하게 한 후에 사용 후 직후, 4일, 2주차에 만족도 평가를 진행하였다. 시험제품 사용 후 인체적용시험대상자가 느끼는 피부보습개선 정도에 대하여 매우 보습감이 느껴짐(10)~나빠짐(0)의 10단계로 인체적용시험대상자 본인이 답하도록 하였다. 연구자는 각 답변에 대한 시험대상자 수의 백분율을 구하여 시험 제품의 효능여부를 판단하여 하기 표7 에 나타냈다. In the liquid crystal emulsion composition prepared in Examples 7 to 12, the liquid crystal formation of Example 11 was the most excellent, and the liquid crystal emulsion composition of Example 11 was applied to 12 adult subjects aged 20-50 for 2 weeks with a test product and a control product twice a day. After taking a shower in the morning and evening, it was used on the area around the eyes, and satisfaction was evaluated immediately after use, 4 days, and 2 weeks after use. After using the test product, the human body application test subject was asked to answer the degree of skin moisturizing improvement felt by the human body application test subject on a 10-step scale of feeling very moisturizing (10) to bad (0). The researcher determined the efficacy of the test product by obtaining the percentage of the number of subjects for each answer, and shown in Table 7 below.

시험제품 사용 후 피부보습기능 개선 만족 정도에 관하여 실시한 만족도 평가에서 각 답변에 대해 ‘좋음’이상 평가한(7점 이상) 인체적용시험대상자 수의 백분율을 구하였다. 평가결과 대조제품은 설문응답자 중 91.7%가 ‘속당김없이 촉촉하다’항목에 좋음으로 평가하였고, 83.3%가 ‘유연해진 느낌이다’에 좋음으로 평가하였다. 또한 75%가 보습감 유지에 만족하여 시험제품이 피부보습기능 만족도가 높음을 확인하였다. In the satisfaction evaluation conducted on the degree of satisfaction with improvement in skin moisturizing function after using the test product, the percentage of the number of test subjects who evaluated 'good' or higher (more than 7 points) for each answer was obtained. As a result of the evaluation, 91.7% of the respondents rated the control product as good in the category of 'moisturize without tightness', and 83.3% rated it as good in 'feeling soft'. In addition, 75% were satisfied with the maintenance of the moisturizing feeling, confirming that the test product was highly satisfied with the skin moisturizing function.

사용직후 시능개선 만족도Satisfaction with performance improvement immediately after use 건강해진
느낌이다.
healthy
It's a feeling.
매끈해진
느낌이다.
smoothed out
It's a feeling.
속당김없이
촉촉하다.
without hesitation
Moist.
보습감이
유지된다.
moisturizing feeling
maintain.
유연해진
느낌이다.
flexible
It's a feeling.
시험제품test product 50.00%50.00% 50.00%50.00% 58.3%58.3% 66.7%66.7% 66.7%66.7% 사용 4일차 기능개선 만족도Satisfaction with function improvement on the 4th day of use 건강해진
느낌이다.
healthy
It's a feeling.
매끈해진
느낌이다.
smoothed out
It's a feeling.
속당김없이
촉촉하다.
without hesitation
Moist.
보습감이
유지된다.
moisturizing feeling
maintain.
유연해진
느낌이다.
flexible
It's a feeling.
시험제품test product 66.7%66.7% 66.7%66.7% 91.7%91.7% 75.0%75.0% 66.7%66.7% 사용 11일차 기능개선 만족도Satisfaction with function improvement on the 11th day of use 건강해진
느낌이다.
healthy
It's a feeling.
매끈해진
느낌이다.
smoothed out
It's a feeling.
속당김없이
촉촉하다.
without hesitation
Moist.
보습감이
유지된다.
moisturizing feeling
maintain.
유연해진
느낌이다.
flexible
It's a feeling.
시험제품test product 66.7%66.7% 66.7%66.7% 83.3%83.3% 75.0%75.0% 83.3%83.3%

Claims (2)

아라키딜알코올(5 내지 30 중량%), 베헤닐알코올(3 내지 20 중량%), 아라키딜글루코사이드(1 내지 10 중량%), 솔비탄세스퀴올리에이트(1 내지 10 중량%), 피토스테롤(1 내지 5 중량%), 피토스핑고신(0.1 내지 1 중량%), 세라마이드엔피(0.1 내지 1 중량%), 옥틸도데칸올(1 내지 10 중량%), 세테아릴알코올(5 내지 50 중량%), 글리세릴스테아레이트(5 내지 50 중량%), 팔미틱애씨드(1 내지 30 중량%), 스테아릭애씨드(1 내지 20 중량%), 미리스틱애씨드(0.1 내지 1 중량%)로 이루어지는 유화제 조성물을 총 중량 대비 10%로 포함하는 것을 특징으로 하는 액정 유화 조성물.Arachidyl alcohol (5 to 30% by weight), behenyl alcohol (3 to 20% by weight), arachidyl glucoside (1 to 10% by weight), sorbitan sesquioleate (1 to 10% by weight), phytosterol (1 to 5% by weight), phytosphingosine (0.1 to 1% by weight), ceramide NP (0.1 to 1% by weight), octyldodecanol (1 to 10% by weight), cetearyl alcohol (5 to 50% by weight) ), glyceryl stearate (5 to 50% by weight), palmitic acid (1 to 30% by weight), stearic acid (1 to 20% by weight), emulsifier composition consisting of myristic acid (0.1 to 1% by weight) A liquid crystal emulsion composition comprising 10% of the total weight. 제 1항에 있어서, 피부장벽개선 및 피부 보습 개선에 효과가 있는 것을 특징으로 하는 액정 유화 조성물.






The liquid crystal emulsion composition according to claim 1, which is characterized in that it is effective in improving skin barrier and skin moisturizing.






KR1020220149460A 2022-11-10 2022-11-10 Liquid crystal emulsion having an excellent effect on skin barrier improvement and skin moisturizing KR20230109079A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020220149460A KR20230109079A (en) 2022-11-10 2022-11-10 Liquid crystal emulsion having an excellent effect on skin barrier improvement and skin moisturizing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020220149460A KR20230109079A (en) 2022-11-10 2022-11-10 Liquid crystal emulsion having an excellent effect on skin barrier improvement and skin moisturizing

Publications (1)

Publication Number Publication Date
KR20230109079A true KR20230109079A (en) 2023-07-19

Family

ID=87425763

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020220149460A KR20230109079A (en) 2022-11-10 2022-11-10 Liquid crystal emulsion having an excellent effect on skin barrier improvement and skin moisturizing

Country Status (1)

Country Link
KR (1) KR20230109079A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190070644A (en) 2017-12-13 2019-06-21 주식회사 코스모코스 Emulsifier composition for skin care formulations and cosmetic composition containing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190070644A (en) 2017-12-13 2019-06-21 주식회사 코스모코스 Emulsifier composition for skin care formulations and cosmetic composition containing the same

Similar Documents

Publication Publication Date Title
KR102451276B1 (en) A cosmetic composition comprising particles containing high ceramide content and preparing method thereof
KR100837558B1 (en) Emulsion composition containing double-stabilized ceramide nano capsule, method for manufacturing the same, and cosmetic composition containing the same
KR101838642B1 (en) Cosmetic composition having excellent moisturizing effect for the skin
CN114177109B (en) Composite ceramide nano composition and preparation method and application thereof
CN111568782B (en) Nanoemulsion composition capable of improving skin barrier and application thereof
KR20130092172A (en) Oil-in-water solid type low irritation and high moisturizing cosmetic composition comprising polyol and emulsifier and manufacturing method thereof
KR20130055069A (en) O/w emulsion having recrystallized particle and cosmetic composition comprising thereof
KR20160141297A (en) Cosmetic composition for skin regeneration containing horse fat having an effect on skin elasticity and method for the manufacture thereof
KR20090017336A (en) Cosmetic composition containing liquid crystal complex for enhancing moisturizing effect on the skin and for reducing skin roughness
JPS61271205A (en) Skin cosmetic
CN108785141A (en) A kind of beautifying liquid, preparation method and applications
WO2002078651A1 (en) Cosmetic composition with improved skin moisturizing properties
KR101096277B1 (en) Cosmetic composition for moisturizing the skin
KR102558185B1 (en) Cosmetic composition containing pseudo-ceramide originated from botanical oil
KR102380796B1 (en) Multilamella emulsion type cosmetic composition
KR101003847B1 (en) Skin -like complex composition
KR102269198B1 (en) Vanishing cream cosmetic composition for exfoliation of skin and preparation method thereof
KR20120057020A (en) Cosmetic composition for moisturizing or improving skin elasticity
KR101155807B1 (en) Cosmetic composition for moisturizing and firming the skin
CN115040438B (en) Skin composition for promoting skin barrier repair function, preparation method and application thereof
KR20130042918A (en) Composition for balacing sebum and moisture of skin and cosmetic compsition comprising it
CN110025508A (en) A kind of essence cream and preparation method thereof preventing striae of pregnancy generation
KR20230109079A (en) Liquid crystal emulsion having an excellent effect on skin barrier improvement and skin moisturizing
CN108938464A (en) A kind of mild makeup remover of deep layer cleaning
KR20110058240A (en) Nanoemulsion containing high content of hydrophobic ingredients and the method for preparing thereof

Legal Events

Date Code Title Description
G15R Request for early publication